The use of compound topical anesthetics: A review

Journal of the American Dental Association

Volumn 138, Issue 10, 2007, Pages 1333-1339

  Kravitz, Neal D ^a  

^a NONE   (United States)

Author keywords

Compounding; Topical anesthetics; U.S. Food and Drug Administration

Indexed keywords

EID: 35548947037     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0048     Document Type: Review

References (15)

1. United States Pharmacopeial Convention. Good compounding practices. In: The United States Pharmacopeia: USP 28: the National Formulary: NF 23: by authority of the United States Pharmacopeial Convention, Inc., meeting at Washington, April 12-16, 2000. Rockville, Md.: United States Pharmacopeial Convention; 2004: 2620, 2457.
2. Department of Health and Human Services, Food and Drug Administration. Registration of producers of drugs and listing of drugs in commercial distribution - 21 CFR part 207 (OMB Control Number 0910-0045) - extension. Fed Regist 2000;65(213):65858-9.
3. Food and Drug Administration Moderization Act of 1997, 21 USC §353A (1997).
4. Jeffcoat MK. Eye of newt, toe of frog: drug compounding: proceed with caution. JADA 2004;135(5):546-8.
5. U.S. Food and Drug Administration. Compliance Policy Guide: Compliance Policy Guidance for FDA Staff and Industry - Sec. 460.200, Pharmacy compounding. Available at: "www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg460-200. html". Accessed Aug. 7, 2007.
6. U.S. Food and Drug Administration. FDA news: FDA warns five firms to stop compounding topical anesthetic creams. Available at: "www.fda.gov/bbs/ topics/NEWS/2006/NEW01516.html". Accessed Aug. 28, 2007.
7. U.S. Food and Drug Administration. FDA public health advisory: Life-threatening side effects with the use of skin products containing numbing ingredients for cosmetic procedures. Available at: "www.fda.gov/cder/drug/ advisory/topical_anesthetics.htm". Accessed Aug. 28, 2007.
8. U.S. Department of Health and Human services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for FDA staff and industry: Marketed Unapproved Drugs - Compliance policy guide, Sec. 440.100 Marketed new drugs without approved NDAs or ANDAs. Available at: "www.fda.gov/cder/guidance/6911fnl.pdf". Accessed Aug. 29, 2007.
9. Pryor GJ, Kilpatrick WR, Opp DR. Local anesthesia in minor lacerations: topical TAC vs lidocaine infiltration. Ann Emerg Med 1980;9(11):568-71.
10. Calatayud J, Gonzalez A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology 2003;98(6):1503-8.
11. Kundu S, Achar S. Principles of office anesthesia, part II: topical anesthesia. Am Fam Physician 2002;66(1):99-102.
12. Kravitz ND, Kusnoto B. Placement of mini-implants with topical anesthetic. J Clin Orthod 2006;40(10):602-4.
13. Kravitz ND, Kusnoto B, Tsay TP, Hohlt WF. The use of temporary anchorage devices for molar intrusion. JADA 2007;138(1)56-64.
14. Graham JW. Profound, needle-free anesthesia in orthodontics. J Clin Orthod 2006;40(12):723-4.
15. Malamed SF. Handbook of local anesthesia. St. Louis: Mosby; 1997:24-36.